BAP Pharma manages the clinical trial supply process including sourcing, delivery and customized solutions to its clients, which include some of the UK’s top pharmaceutical companies. The decision to expand its operations to New Jersey was made in response to the company’s rapid growth, according to founder and managing director, Bashir Parkar. Pharmaceutical industry veteran Lucas Nigro will manage the U.S. headquarters.
“Since 2011, BAP Pharma has been establishing itself as a global leader in the clinical trial supply sector based on attention to quality and best-in-class client service,” said Mr. Parkar. “The opening of our U.S. headquarters in New Jersey is an important milestone for our company and will enhance our ability to provide fast, seamless service to our clients.”
The new HQ is equipped with state-of-the-art, fully enclosed temperature controlled ambient and cold room storage facilities.
“The facility and location proved a perfect fit for our company,” said Mr. Parkar. “Its proximity to a significant number of global pharmaceutical and biotechnology companies, including our current clients, made it particularly attractive. New Jersey’s excellent transportation network also enhances our ability to deliver products quickly and efficiently throughout the region and around the world.”